CELLTech 2013, 22-23 January, 2013, San Diego, USA

CELLTech 2013, 22-23 January, 2013, San Diego, United States

http://selectbiosciences.com/conferences/index.aspx?conf=CT2013

 

Welcome to the inaugural CellTech2013 conference and exhibition. SelectBio has re-branded the Stem Cells World Congress / Circulating Tumour Cells / Cell Culture meeting for 2013 and expanded the scope of the event to include five conference tracks, bringing together all the key stakeholders in this space, to enhance the overall experience of attendees:

The Tracks:
     ◆ Cell-based Assays
     ◆ Flow Cytometry 
     ◆ Cell Culture 
     ◆ Circulating Tumor Cells (CTCs) 
     ◆ Cancer & Stem Cells 

Cell-based Assays  –

There is constant demand to refine this powerful research tool.  This conference will present the latest information on how to improve the accuracy of this technique - including optimising cellular conditions, developing quantitative technologies and enhancement of biomarkers.  Speakers will focus on the ways in which this technique facilitates research in numerous therapeutic areas, notably stem cells and oncology.

 

Keynote Speakers:

Hakim Djaballah
Director, Memorial Sloan Kettering Cancer Center

Stephen Minger
Global Head R&D, GE Healthcare Life Sciences

 

Agenda Topics

     ◆ Apoptosis Assays
     ◆ Assays for Phenotypic Changes: Invasion, Migration, Angiogenesis
     ◆ Case Studies from Biotechnology and Pharmaceutical Companies
     ◆ Elements of Assay Development: A Nuts-and-Bolts Perspective
     ◆ High-Content Analysis (HCA) Assays
     ◆ Instrumentation for Cell-based Assays
     ◆ Metabolism-monitoring Assays
     ◆ Morphology Changes as a Readout
     ◆ Reporter Gene Assays and their Utility for Drug Discovery Projects

 

Cancer & Stem Cells –

SelectBio has designed this conference track to bring together researchers and industry participants focusing on the utility of stem cells for the treatment of various types of cancer.

There is much interest in the field to use stem cells for treating hematological as well as solid tumors.  HSCTs using bone marrow, PBLs, and cord blood have paved the way for such treatments to be possible and successful.

We examine, in this conference track, the basic and translational research studies being performed to bring stem cells to the oncology field.We also examine cancer stem cells (CSCs), an often controversial topic, but nevertheless important for understanding cancer propagation at the basic level, and also as a means to target tumors.

 

Keynote Speakers:  

Karen Aboody
Associate Professor, City of Hope National Med Center and Beckman Research Institute

Ellen Feigal
Senior Vice President, The California Institute for Regenerative Medicine

 

Agenda Topics

     ◆ Clinical Trials Focusing on Targeting Cancer Stem Cells (CSCs) 
     ◆ Clinical Trials Status on Stem Cell Therapies for Cancer 
     ◆ Development of Stem Cell Therapies for Treating Cancers 
            • Hematological Cancers 
            • Solid Tumors
     ◆ Emerging Companies’ Presentations 
     ◆ Grants and Funding Sources for Basic Translational Research Focusing on Stem Cell Therapies for Cancer 
     ◆ Role of CSCs in Progression of Disease and Metastasis 
     ◆ What will it Take to Successfully Translate Stem Cell Research/Cellular Therapy to Focus upon Problems in the Oncology Field?

 

Flow Cytometry –

The field of Flow Cytometry is undergoing an expansion driven in large part by the need for cellular analyses in both research and clinical settings.  Indeed, Select Bio is focusing on this space and is addressing some of the key topics in this the Flow Cytometry track of the CellTech 2013 Conference.

 

Keynote Speakers:

David Galbraith
Professor, University of Arizona

John Nolan
Principal Investigator, La Jolla Bioengineering Insitute

Paul Robinson
Professor of Biomedical Engineering, Purdue University Cytometry Laboratories

 

Agenda Topics

     ◆ Flow Cytometry in Regenerative Medicine 
     ◆ Flow Spectroscopy 
     ◆ Imaging 
     ◆ Software and Informatics 
     ◆ Translational Cytometry 
     ◆ Tumour Cytometry

 

Cell Culture –

 

Cell Culture 2013 will deliver an array of presentations on the latest techniques and technologies being used to overcome common problems associated with producing cell culture. Talks on methods for the prevention of cell line cross contamination, monitoring of cells, optimizing process development, culture strategies and the manipulation of cultured cells will be given.

 

Keynote Speakers:

Mohamed Al-Rubeai
Director, University College of Dublin

Matthew Croughan
Professor and Director of the Amgen Bioprocessing Center at KGI, Keck Graduate Institute of Claremont, California

 

Agenda Topics

     ◆ 3D Cell Culture 
     ◆ Application & Manipulation of Cultured Cells 
     ◆ Cell Line Development & Culture Strategies 
     ◆ Future Prospects for Cell Culture Systems 
     ◆ Preventing Cell Line Cross Contamination

 

Circulating Tumor Cells –

 

Our 2nd annual Circulating Tumour Cells 2012 conference is expanding on the interest expressed in the CTC sessions of our very popular Single Cell Analysis conferences.

With oncologists increasingly using CTCs to gather prognostic information on their patients, it is more and more apparent that CTCs can offer clinicians a non-invasive means of sampling for genetic markers, monitoring treatment responsiveness, aiding in treatment decision-making and indicating novel drug targets.

However, there are still issues and questions being raised about the clinical significance of CTCs, as well as the need to improve sensitivity, reproducibility and reliability of their use in disease monitoring. To solve these problems there is a real need for increased collaboration and understanding if the industry is to effectively use CTCs to improve cancer survival rates and provide significant cost-savings.

The Circulating Tumor Cells 2012 conference offers delegates 2 days of world class speakers who are at the forefront of the field and whose talks will be exploring, as well as attempting to answer, some of these CTC questions.

 

Keynote Speakers:

Dario Marchetti
Professor/Director, Baylor College of Medicine

Katharina Pachmann
Professor, University of Jena

 

Agenda Topics

     ◆ CTCs as Prognostic or Predictive Biomarkers for Cancer 
     ◆ Early Cancer Detection 
     ◆ EMT in Cell Generation and Survival 
     ◆ Isolation and Analysis of CTCs: Emerging Technologies Impacting the Field 
     ◆ Methods of Enumeration of CTCs as a Predictor 
     ◆ Novel Methods for Detection and Profiling 
     ◆ Significance of CTCs in Various Types of Cancer: Liquid Tumors vs. Solid Tumors 
     ◆ The Formation and Markers for Circulating Tumor Cells 
     ◆ The Use of Circulating Tumour Cells in Clinical Development 
     ◆ Understanding the Role of EMT in Metastasis

 

Sponsorship and Exhibition Opportunities

 

Aaron Woodley, Exhibition Manager
a.woodley@selectbio.com
+44 (0)1787 315129

Other enquiries

k.shah@selectbio.com

+44 (0) 1787 315110

 

Registration

Now, when you buy one full priced delegate pass, you can share the experience with a colleague for FREE!

This promotion expires on 31^st December 2012, so be sure to register as soon as possible to take advantage!

 

Terms and Conditions apply.  Visit website for more information, and to register.

 

Venue

Crowne Plaza San Diego

2270 Hotel Circle North
San Diego
CA 92018
United States
Tel: 619 297 1101 

 

Visit the website for more information, including special room rates.